Sponsors (4)
Official title: To preserve lawful hemp commerce while protecting consumers from high-THC synthetic intoxicants, and for other purposes.
Introduced July 22, 2026 by Garland H. Barr · Last progress July 22, 2026
The bill creates a comprehensive federal framework that increases consumer safety, regulatory clarity, and market protections for compliant hemp products, but does so at the cost of sizable compliance costs and new criminal/administrative regimes that could burden small businesses, constrain state/Tribal flexibility, and raise civil‑liberties and enforcement challenges.
Consumers (including families, seniors, and veterans) will get safer, better‑labeled hemp products with standardized testing, per‑serving THC disclosure, mandatory warnings, QR-linked certificates of analysis, and a national 21+ minimum and ban on child‑oriented packaging, reducing accidental use by minors and lowering health risks.
Businesses, regulators, and consumers gain nationwide legal clarity and a unified federal framework—clear definitions of hemp and hemp‑derived cannabinoid products, classification under the FD&C Act, interstate transit protection for compliant shipments, and an explicit permitting/tax framework—reducing cross‑state confusion and legal uncertainty.
Hemp growers and independent producers gain economic protections and greater production flexibility—raising the allowable THC threshold for hemp up to 1% reduces crop losses, and new statutory protections for retailers and small manufacturers limit anti‑competitive wholesale practices.
Small hemp businesses (growers, processors, manufacturers, retailers) face substantially higher compliance costs—from U.S.-only sourcing preferences, ISO lab testing, new labeling and QR/COA requirements, permits, taxes, and administrative obligations—which could raise consumer prices, force business exits, and consolidate the market.
Individuals (especially young adults and lawful hemp users) face new criminalization and rights risks—national 21+ possession/sales minimum, penalties for under‑21 possession, DUI exposure under alcohol‑style impairment rules, and broader disclosure of business information—raising civil‑liberties and privacy concerns.
State, territorial, and Tribal autonomy is constrained: while local authorities keep some stricter rules, federal transit protections and uniform federal definitions limit the ability of States and Tribes to fully block in‑transit compliant hemp products, and failure to adopt federal impaired‑driving standards risks highway funding penalties.
Based on analysis of 11 sections of legislative text.
Creates a federal regulatory, tax, and oversight regime for hemp-derived cannabinoid products, raises hemp THC limit to 1%, reclassifies many cannabinoid products as foods/supplements, and conditions highway funds on state impaired-driving laws.
Creates a federal framework that defines, taxes, regulates, and promotes hemp-derived cannabinoid products while preserving state, territorial, and tribal authority that meets minimum standards. It raises the THC threshold for hemp, classifies many hemp cannabinoid products as foods/dietary supplements under the FD&C Act, allows some Medicare Advantage and care-model coverage, establishes new federal excise taxes and a trust fund for oversight, bans certain anti‑competitive distribution practices, restricts distribution of unfinished cannabinoid ingredients to permitted manufacturers, and conditions a portion of federal highway funding on state zero-tolerance impaired‑driving laws covering hemp impairment starting in FY2027. The bill makes coordinated changes across agricultural law, the FD&C Act, tax law, Medicare rules, criminal/civil penalties for certain transactions, and highway funding rules. Many provisions take effect on regulatory or statutory timelines (Treasury regulations within one year; Medicare Advantage changes the first plan year after enactment; CMI incentive changes one year after enactment; highway funding condition begins FY2027).